DR. WASSIM MOUSSA BAZZI M.D. NPI 1316106537

NPI Details

DR. Wassim Moussa Bazzi, M.D. is an urology in Dearborn, MI with 19 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. DR. Wassim Moussa Bazzi, M.D. NPI is 1316106537. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:2006

The provider's business location address is:

18100 OAKWOOD BLVD STE 315
DEARBORN, MI
ZIP 48124-085
Phone: (313) 271-0066
Fax: (313) 271-1047

The NPI 1316106537 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, denosumab, 1 mg (HCPCS:J0897)
• Automated urinalysis test (HCPCS:81003)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Complete ultrasound scan behind abdominal cavity (HCPCS:76770)
• Identification of organisms by genetic analysis, amplified probe technique (HCPCS:87150)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Liver function blood test panel (HCPCS:80076)
• Testosterone (hormone) level, total (HCPCS:84403)
• Phosphate level (HCPCS:84100)
• Vitamin d-3 level (HCPCS:82306)
• Magnesium level (HCPCS:83735)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique (HCPCS:87491)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique (HCPCS:87591)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Imaging of urinary tract following injection of a contrast agent (HCPCS:74420)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Limited ultrasound scan behind abdominal cavity (HCPCS:76775)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Complex measurement of pressure of urine flow in bladder with voiding pressure studies (HCPCS:51728)
• Detection test for gardnerella vaginalis (bacteria), amplified probe technique (HCPCS:87511)
• Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique (HCPCS:87661)
• Insertion of stent in ureter using an endoscope (HCPCS:52332)
• Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (HCPCS:87186)
• Simple insertion of temporary bladder tube (HCPCS:51702)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Biopsy of prostate gland (HCPCS:55700)
• Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope (HCPCS:52310)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm (HCPCS:52234)
• Crushing of stone of ureter with insertion of stent using an endoscope (HCPCS:52356)
• Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope (HCPCS:52601)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 6/3/2008 and was last updated on 1/25/2018.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.